User: TahirAmin Topic: IP
Category: patent-legal-regime :: india
Last updated: Apr 26 2017 02:03 IST RSS 2.0
 
1 to 20 of 3,366    
Science fairs can wait; get your finding patented first 26.4.2017 TOI: Chennai
Also found in: [+]
The expanding universe of IP 25.4.2017 Hindu: Op-Ed
Granting data exclusivity for clinical trials would undermine access to medicines
Also found in: [+]
Govt's generic push will dent Rs 90,000-cr branded pharma market 24.4.2017 Business Standard: Companies & Industry
To make medicines cheaper, in another measure, govt added 200 drug formulations to NLEM list
Also found in: [+]
S. African band keen on collaborating with Indian artistes 23.4.2017 Cinema-Showbiz
South African industrial percussion act 1st Project, who are here for their maiden performance, said they are interested in collaborating with Indian artistes and that even after performing in over 25 countries, they love to perform for their "favourite" Indian audiences.
Also found in: [+]
Planning a career in law? Intellectual property rights is the in-thing 18.4.2017 TOI: Chennai
Also found in: [+]
Mission admission: For keepers of creativity 18.4.2017 TOI: Chennai
Also found in: [+]
RSS-backed SJM declares 2017 'anti-China year' 14.4.2017 Rediff: Business
'I will be happy if walls are built between India and China!'
Also found in: [+]
Donald Trump picks two PIOs for key jobs 9.4.2017 TOI: All Headlines
Donald Trump picks two PIOs for key jobs
Also found in: [+]
IPA punches holes into drug pricing policy implementation 4.4.2017 ET: Pharma
"This is not a good sign. It is indicative of trust deficit in the regulatory mechanism and administrative machinery, be it the NPPA or CDSCO," it added.
Also found in: [+]
IPA punches holes into drug pricing policy implementation 4.4.2017 TOI: All Headlines
IPA punches holes into drug pricing policy implementation
Also found in: [+]
US slams India's 'restrictive' policies in foreign investment, trade 3.4.2017 Business Standard: News Now
Criticises India's policy in retail trading; insurance, banking, telecom, digital sectors
Also found in: [+]
Wary of foreign influence, Hindu activists force Monsanto to quit India 29.3.2017 Business Standard: News Now
A little-known cotton seed company has taken on Monsanto, with the aid of a right-wing Hindu group
Also found in: [+]
IIT Kharagpur hosts students from George Washington University Law School 27.3.2017 TOI: Calcutta Times
Also found in: [+]
`India–EFTA trade talks may adversely impact access to medicines in developing countries' 23.3.2017 TOI: India
Also found in: [+]
US needs highly skilled workers to keep innovating: Victoria A Espinel, Business Software Alliance 21.3.2017 ET: Opinion
We as an industry have more jobs that we can fill, we need to have high skilled workers in United States and we need to also welcome high skilled workers from other countries, said Victoria A Espinel.
Also found in: [+]
Now, even Indian lawyers bank on Artificial Intelligence 21.3.2017 Rediff: Business
With the demand for lower costs in process driven activities and a move away from the high rate, billable hours of legal services, AI platforms are being used internationally in many legal tasks.
Also found in: [+]
Protecting intellectual property or monopoly profits? 19.3.2017 Deccan Herald - Analysis
The Global Intellectual Property Centre of the US Chamber of Commerce has come out with an International Index of Intellectual Property. It shows India third from the bottom. The report has noted: "India's score is unchanged as patent protection remains outside of international best practices..."; "All countries should look at the index and incorporate the infinite possibilities to improve their IP environment and encourage that the next greatest innovation takes place on their soil"; "The Indian government's rhetoric to improve IP environment was yet to translate into action." Is this cause for worry, as the report and the newspapers seem to imply? When an index for ranking is constructed, it is always for a purpose. This was exemplified by the United Nations Development Programme's (UNDP) Index of Human Development, which highlighted the fact that growth did not necessarily correlate with positive changes in wellbeing represented by education, health and income. It did not 'trickle down'. The rankings ...
Also found in: [+]
U.S. trade nominee for ‘aggressive’ steps on IP 16.3.2017 Hindu: Business
IPRs have been a bone of contention between U.S., India
Also found in: [+]
Indian drug makers can export patented meds for approval: Delhi High Court 8.3.2017 ET: Pharma
Natco and Alembic, however, were directed to undertake that during the life of the respective patent, they will not export the respective patented invention for purposes other than those specified in section 107A.
Also found in: [+]
Delhi HC rules in favour of Indian pharma manufacturers Natco and Alembic 8.3.2017 All Companies Stories
The Delhi High Court on Wednesday allowed Indian drug manufacturers Natco Pharma and Alembic Pharmaceuticals to export Sorafinat and Rivaroxiban, generics of German pharma major Bayer's own cancer and blood thinning medicines. Bayer had initiated proceedings against the two Indian pharma companies to stop them from exporting the drug, which the defendants had claimed were being exported for purposes of experimentation and generation of valuable clinical trial data. Bayer had opposed this stance and argued that such exports did not meet the exceptions to patent infringement provided under Section 107A of the Indian Patents Act, 1970, as they violated conditions of compulsory licenses (Natco) and exceeded reasonable quantities (Alembic). Bayer had claimed that under the compulsory license provided to Natco, the company could only sell Sorafinat within India and that Alembic could not take benefit of the exception as they had exported over 90 kilograms of Rivaroxiban, worth around Rs 3 .
Also found in: [+]
1 to 20 of 3,366